Shares of ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB – Get Free Report) passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $59.59 and traded as low as $55.06. ProShares Ultra Nasdaq Biotechnology shares last traded at $55.17, with a volume of 9,601 shares.
ProShares Ultra Nasdaq Biotechnology Stock Performance
The company has a fifty day simple moving average of $53.40 and a two-hundred day simple moving average of $59.54.
ProShares Ultra Nasdaq Biotechnology Increases Dividend
The company also recently declared a dividend, which was paid on Tuesday, December 31st. Stockholders of record on Monday, December 23rd were issued a $0.3964 dividend. This is a positive change from ProShares Ultra Nasdaq Biotechnology’s previous dividend of $0.15. The ex-dividend date of this dividend was Monday, December 23rd.
Institutional Trading of ProShares Ultra Nasdaq Biotechnology
ProShares Ultra Nasdaq Biotechnology Company Profile
ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period.
See Also
- Five stocks we like better than ProShares Ultra Nasdaq Biotechnology
- ETF Screener: Uses and Step-by-Step Guide
- Symbotic Shares Down 37%βIs It Time for Bravery or Caution?
- 3 Small Caps With Big Return Potential
- High-Yield Healthcare: 3 Stocks With Strong Dividends
- What is the FTSE 100 index?
- Beyond the Bargain Bin: 3 Stocks Leading Discount Retail
Receive News & Ratings for ProShares Ultra Nasdaq Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares Ultra Nasdaq Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.